BioSpace News Archive

Biotech Bay

EndoClot Expands GI Hemostasis Portfolio With Launch of EndoClot® Adhesive

EndoClot Plus, Inc., a privately held medical device company founded by surgeons and biomaterial scientists announces the CE approval of EndoClot® Adhesive manufactured by EndoClot Plus Co., Ltd. located in Suzhou, China.

May 24, 2018
·
2 min read
Business

San Diego-based Epigen Biosciences enters a collaboration to license its LPA1 Receptor small molecule program to Novo Nordisk A/S for up to USD 200 Million

Epigen Biosciences, Inc. announced today that it has entered into a collaboration agreement with Novo Nordisk...

May 24, 2018
·
2 min read
Business

Softbox acquires Cold Tech Systems to further expand presence in Latin America

Softbox announces the acquisition of Cold Tech Systems.

May 24, 2018
·
3 min read
New Medtronic Data Show Significant Blood Pressure Lowering Effect of Renal Denervation in Patients Taking Anti-Hypertensive Medication

Medtronic plc announced first-ever-data from the SPYRAL HTN-ON MED Study.

May 24, 2018
·
5 min read
Business

DermTech Announces Addition of Cynthia Collins to Board of Directors

Cindy is a recognized leader in diagnostics, life sciences, and therapeutics. Prior to her most recent position as CEO of Human Longevity Inc.

May 24, 2018
·
2 min read
BioMidwest

Best Particle Therapy, Inc. is Developing a Highly Revolutionary New Treatment for Cancer Therapy

The most precise and conformal Cancer Therapy, using hypo-fractionation, supported by a range of the most advanced cyclotrons for research and radioisotope production for medical diagnosis and therapy in the world

May 24, 2018
·
2 min read
Business

CollPlant Reports First Quarter 2018 Financial Results and Provides Business Update

CollPlant is a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products

May 24, 2018
·
29 min read
PiCSO therapy reduces infarct size in STEMI patients.

Miracor Medical announces new publication at EuroPCR.

May 24, 2018
·
2 min read
Drug Development

Realm Therapeutics Completes Enrollment in Phase 2 Study of PR022 for Atopic Dermatitis

Company Further Strengthens IP Portfolio with New USPTO Notice of Allowance

May 24, 2018
·
8 min read
Business

Foundation Medicine Establishes Immuno-Oncology Companion Diagnostics Collaboration with Merck

Pan-Cancer MSI Companion Diagnostic for KEYTRUDA® (pembrolizumab) Planned for Inclusion on FoundationOne CDx™

May 24, 2018
·
6 min read